LTRN · Lantern Pharma Inc.
AI read · Bad for LTRN
The AI's read
The deadline gives Lantern Pharma a chance to fix the listing problem. Failing to do so could remove its shares from Nasdaq, making them harder to trade and weakening the company’s access to investors. That chance to fix the problem helps, but the risk of removal makes this negative for Lantern Pharma.